Another reason they may not make it to the Nasdaq is the minimum 75% shareholder approval they require. The specifics of this deal is not impressing anyone, and the arguments are weak at best. Also noticed that the Bioshares team has just written to clients advising them to vote against the move.
bta won't make it to the nasdaq, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)